Market share of generics in European countries 2022

Market share of generics and biosimilars in selected European countries in 2022

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2024

Region

Europe

Survey time period

2022

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, Ireland, Hungary, Slovenia, U.K.: share of generics and biosimilars in pharmacy market sales.
Austria, Belgium, France, Germany, Greece, Italy, Luxembourg, Netherlands, Portugal, Spain: share of generics and biosimilars in reimbursable pharmacy market sales.
Latvia, Lithuania, Norway, Poland, Romania, Russia, Serbia, Slovakia, Sweden, Switzerland, Turkey: share of generics and biosimilars in total market sales.
Ireland, Latvia, Lithuania, Russia: 2021 data; Cyprus, Iceland, Malta: data not available.
France: data relate only to those active substances listed on the official list of medicines.
‘Generics’ are defined as medicines based on active substances that are out of patent and which are marketed under different names from that of the original branded medicines.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Statistics on " Pharmaceutical trends in Europe "

Other statistics that may interest you Pharmaceutical trends in Europe

Overview

6

Leading companies

7

Employment

6

R&D / Clinical trials / Approvals

8

Self-medication market

6

Further related statistics

16
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.